2025 WMIF | Obesity and Metabolic Disorders | Emerging Treatments

Описание: Obesity and related metabolic disorders are at the forefront of a medical transformation—fueled by advances in therapeutic agents, novel targets, and evolving care strategies. This panel builds on prior discussions to examine the next wave of breakthroughs shaping the field that extend beyond the current GLP-1s, such as amylin agonists, and other orthogonal mechanisms in development. Experts will explore progress in single-agent and multi-target therapies, structure-function insights, the latest clinical data, and challenges in side effect management and reimbursement. This session will map the future of care—where science, policy, and patient experience converge.

Moderator
Tim Anderson, MD, Pharmaceutical Analyst, BofA Securities

Speakers
Caroline Apovian, MD, Co-Director, Center for Weight Management and Wellness, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School
Mehmet Furkan Burak, MD, Endocrinologist, Brigham and Women’s Hospital; Instructor in Medicine, Harvard Medical School
Steven Grinspoon, MD, Chief, Metabolism Unit, Massachusetts General Hospital; Professor of Medicine, Harvard Medical School
Melanie Haines, MD, Associate Physician, Neuroendocrine Unit, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School